Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer

BACKGROUND: BRCA1/BRCA2 germ line (GL) mutation carriers with pancreatic adenocarcinoma (PDAC) may have distinct outcomes. We recently described an apparent more favourable prognosis of surgically resected BRCA-associated PDAC patients in a single-arm, uncontrolled, retrospective study. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Golan, Talia, Sella, Tal, O'Reilly, Eileen M, Katz, Matthew H G, Epelbaum, Ron, Kelsen, David P, Borgida, Ayelet, Maynard, Hannah, Kindler, Hedy, Friedmen, Eitan, Javle, Milind, Gallinger, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355924/
https://www.ncbi.nlm.nih.gov/pubmed/28183138
http://dx.doi.org/10.1038/bjc.2017.19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355924/
https://www.ncbi.nlm.nih.gov/pubmed/28183138
http://dx.doi.org/10.1038/bjc.2017.19

Ejemplares similares